Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings

Modified to extend deadline of application due date to 3/22/2024, increase eligibility for Component B applicants, reduce description of research plan for Component B. - Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 - 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION - The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.

Modified to extend deadline for application due date to 3/22/2024, increase eligibility for Component B applicants, reduce description of research plan for Component B, - Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 - 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION - The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.

Please see NOFO for update to definitions. - PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 - 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION - The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.

Updating the date of the Pre-Application call. All other information and application package to remain the same. - PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 - 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION - The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.

The purpose of this notice of funding opportunity (NOFO) is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components:Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Award recipients are expected to collaborate to establish a standard investigative protocol.Component B: A coordinating center to provide data storage (if needed), harmonize data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. Given the low prevalence in the general population, this NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs.In the past decade, large-scale glaucoma studies funded by CDC among high-risk groups have demonstrated success in screening and follow-up care to slow disease progression through innovative delivery programs. CDC intends to further this research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.